Abstract:Background: Stress-related mental health disorders have steadily increased and contributed to a worldwide disease burden with up to 50% experiencing a stress-related mental health disorder worldwide. Data suggest that only approximately 20%-65% of individuals receive treatment. This gap in receiving treatment may be attributed to barriers such as limited treatment access, negative stigma surrounding mental health treatment, approachability (ie, not having a usual treatment plan or provider), affordability (ie, lack of insurance coverage and high treatment cost), and availability (ie, long waits for appointments) leaving those who need treatment without necessary care. To mitigate the limited access mental health treatment, there has been a rise in the application and study of digital mental health interventions. As such, there is an urgent need and opportunity for effective digital mental health interventions to alleviate stress symptoms, potentially reducing adverse outcomes of stress-related disorders. Objective: This study examined if app-based guided mindfulness could improve subjective levels of stress and influence physiological markers of stress reactivity in a population with elevated symptoms of stress. Methods: The study included 163 participants who had moderate to high perceived stress as assessed by the Perceived Stress Scale (PSS-10). Participants were randomly allocated to 1 of 5 groups: a digital guided program designed to alleviate stress (Managing Stress), a digital mindfulness fundamentals course (Basics), digitally delivered breathing exercises, an active control intervention (Audiobook), and a Waitlist Control group. The 3 formats of mindfulness interventions (Managing Stress, Basics, and Breathing) all had a total duration of 300 minutes spanning 20-30 days. Primary outcome measures were perceived stress using the PSS-10, self-reported sleep quality using the Pittsburgh Sleep Quality Index, and trait mindfulness using the Mindful Attention Awareness Scale. To probe the effects of physiological stress, an acute stress manipulation task was included, specifically the cold pressor task (CPT). Heart rate variability was collected before, during, and after exposure to the CPT and used as a measure of physiological stress. Results: The results showed that PSS-10 and Pittsburgh Sleep Quality Index scores for the Managing Stress (all P<.001) and Basics (all P≤.002) groups were significantly reduced between preintervention and postintervention periods, while no significant differences were reported for the other groups. No significant differences among groups were reported for Mindful Attention Awareness Scale (P=.13). The physiological results revealed that the Managing Stress (P<.001) and Basics (P=.01) groups displayed reduced physiological stress reactivity between the preintervention and postintervention periods on the CPT. There were no significant differences reported for the other groups. Conclusions: These results demonstrate efficacy of app-based mindfulness in a population with moderate to high stress on improving self-reported stress, sleep quality, and physiological measures of stress during an acute stress manipulation task. Trial registration: ClinicalTrials.gov NCT05832632; https://www.clinicaltrials.gov/ct2/show/NCT05832632.

Spiritual Mindfulness based on Benson Relaxation in the Management of Stress Levels Reduction on Type 2 DM Patients

The Effectiveness of Mindfulness Based Stress Reduction Intervention on Emotion Regulation Problems and Blood Sugar Control in Patients With Diabetes Type II

Mindfulness eating based on spiritual interventions on diet compliance and blood sugar levels in type 2 DM patients

THE EFFECT OF PROGRESSIVE MUSCLE RELAXATION ON REDUCING STRESS AND BLOOD SUGAR IN TYPE 2 DIABETES MELLITUS PATIENTS IN THE WORK AREA OF TANIWEL PUBLIC HEALTH CENTER

Effects of Stress Reduction on Cardiovascular Risk Factors in Type 2 Diabetes Patients with Early Kidney Disease – Results of a Randomized Controlled Trial (HEIDIS)

Efficacy of mindfulness-based stress reduction in emerging adults with poorly controlled, type 1 diabetes: A pilot randomized controlled trial

A blended mindfulness-based stress reduction program to improve diabetes self-management among people with type 2 diabetes mellitus: a mediation effect analysis

The Effectiveness of Cognitive Behavioral Stress Management on Health-Related Quality of Life, Diabetes Management Self-Efficacy, and Treatment Adherence in Type 2 Diabetes

Mindfulness Meditation as Adjunctive Therapy to Improve the Glycemic Care and Quality of Life in Patients with Type 1 Diabetes

Self-Compassion Reduces the Destructive Effects of Perceived Stress on Psychological Well-Being and Self-Care Behaviors: Results from Type II Diabetes Mellitus Patients

The Effect of Diabetic Gymnastics on Reducing Blood Sugar Levels, Stress, and Anxiety in Patients with Type II Diabetes Mellitus

Effects of Mindfulness-Based Stress Reduction on Blood Pressure, Mental Health, and Quality of Life in Hypertensive Adult Women: A Randomized Clinical Trial Study

Effectiveness of Mindfulness Meditation on Depression, Anxiety, and Stress among Undergraduate Nursing Students: A Quasi-experimental Study

Effect of Mindfulness Breathing Meditation on Depression, Anxiety, and Stress: A Randomized Controlled Trial among University Students

The Effectiveness of Acupressure and Smart Gymnastic on Fasting Blood Sugar Levels among Patients with Type II Diabetes Mellitus

App-Based Mindfulness for Attenuation of Subjective and Physiological Stress Reactivity in a Population With Elevated Stress: Randomized Controlled Trial

BLOOD PRESSURE CONTROL WITH BENSON RELAXATION TECHNIQUE IN HYPERTENSIVE PATIENTS

Self-administered mindfulness interventions reduce stress in a large, randomized controlled multi-site study

Treatment of type 2 diabetes and stress using neuro-emotional technique: case report

Meditation for stress and anxiety relief in undergraduate students: a randomized clinical trial

Educational intervention on perceived stress among adults with type 2 diabetes and metabolic syndrome: a non-randomized clinical trial